Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate - Concepedia

Concepedia

Publication | Closed Access

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

377

Citations

17

References

2001

Year

C.A. Lawton, Kathryn Winter, Kevin Murray, Mitchell Machtay, J Mesić, Gerald E. Hanks, Christopher T. Coughlin, Miljenko V. Pilepich

International Journal of Radiation Oncology*Biology*Physics

UrologyRadiation TherapyMedicineStandard Radiation TherapyProstatic DiseaseOncologyRadiation OncologyAndrogen SuppressionPotential Benefit

References

	Year	Citations

Page 1